Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380783 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis
A Phase 2 study, sponsored by Allergan.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00380783 is a Phase 2 study that was terminated before completion, run by Allergan. The registered enrollment target is 2 participants.
The verdict
NCT00380783, a Phase 2 study, was terminated before completion, sponsored by Allergan.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with painful bladder syndrome/interstitial cystitis
Interventions
- DRUG AGN 203818
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00380783
The ClinicalTrials.gov registry entry for NCT00380783 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AGN 203818 is the first listed.
NCT00380783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00380783 about?
NCT00380783 is a clinical study titled "Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis". This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with painful bladder syndrome/interstitial cystitis
What is the current status of trial NCT00380783?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2006-10. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00380783?
The interventions under investigation include: AGN 203818 (DRUG).
Who is sponsoring clinical trial NCT00380783?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.